Skip to main content
ADVANCED MEDICAL SOLUTIONS GROUP PLC logo

ADVANCED MEDICAL SOLUTIONS GROUP PLC — Investor Relations & Filings

Ticker · AMS ISIN · GB0004536594 LEI · 213800HJP6OWOSZI1L74 IL Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2025-09-09 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL AMS

About ADVANCED MEDICAL SOLUTIONS GROUP PLC

https://admedsol.com/

Advanced Medical Solutions Group plc is a world-leading independent developer and manufacturer of innovative tissue-healing technologies. The company operates through two primary divisions: Surgical and Woundcare. The Surgical portfolio includes a range of products such as tissue adhesives, sutures, haemostats, and internal fixation devices designed for tissue closure and sealing. The Woundcare division focuses on advanced products for managing acute and chronic wounds, utilizing high-performance natural and synthetic polymers. The company is dedicated to delivering high-quality, innovative solutions that improve patient outcomes and provide value to clinicians and healthcare payors.

Recent filings

Filing Released Lang Actions
Block listing Interim Review
Share Issue/Capital Change Classification · 100% confidence The document is a notification regarding a 'Block Admission' return, which is a standard regulatory requirement for companies listed on the London Stock Exchange (AIM) to report on the issuance of shares under various employee share schemes. This falls under the category of share capital changes and regulatory reporting of share issuance. Since it specifically details the movement of shares under block admission arrangements, it is best classified as a share issue/capital change announcement.
2025-09-09 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a standard 'Total Voting Rights' announcement issued via the London Stock Exchange's RNS (Regulatory News Service). It provides the total number of shares and voting rights in accordance with the FCA's Disclosure and Transparency Rule 5.6.1. Since this is a regulatory notification regarding share capital and voting rights that does not fit into specific categories like 'Share Issue' (which implies a change event) or 'Major Shareholding' (which implies a third-party notification), it is best classified as a general Regulatory Filing (RNS).
2025-09-01 English
Notice of Interim Results
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) titled 'Notice of Interim Results'. It informs shareholders and analysts about the upcoming release date of the company's interim financial results and provides details on how to access the briefing and presentation. It does not contain the actual financial results, but rather serves as a notification of the report's future publication. Therefore, it falls under the 'Report Publication Announcement' (RPA) category.
2025-09-01 English
Total Voting Rights
Regulatory Filings Classification · 100% confidence The document is a 'Total Voting Rights' announcement issued in accordance with the FCA's Disclosure and Transparency Rules. It provides the total number of shares and voting rights to assist shareholders in calculating their notification obligations. This type of regulatory disclosure does not fit into specific categories like financial reports or M&A, and is standardly classified as a Regulatory Filing (RNS) within the provided schema.
2025-07-31 English
Half Year Trading Update
Earnings Release Classification · 100% confidence The document is titled 'Half Year Trading Update' and provides preliminary financial figures (revenues and adjusted EBITDA) for the six months ended 30 June 2025, comparing them to the previous year (H1 2024). This content strongly indicates an announcement of periodic financial results, which aligns with the definition of an Earnings Release (ER). Although it covers a half-year period, which might suggest an Interim Report (IR), the text explicitly states it is a 'Trading Update' providing key highlights and estimates, and it announces the date for the full 'interim results' (September 17, 2025). Therefore, this document serves as the initial, high-level announcement of the period's performance, classifying it as an Earnings Release (ER). The presence of the RNS Number and the footer referencing RNS confirms it is a regulatory announcement. H1 2025
2025-07-15 English
Group of companies' accounts made up to 2024-12-31
Regulatory Filings
2025-07-02 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.